Retevmo Capsule
Product Images NDC 0002-3977

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Retevmo (NDC 0002-3977). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eli Lilly And Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Retevmo 40mg 60ct 067 01

Retevmo 40 mg capsules label showing the product name and strength with the active ingredient selpercatinib. The label indicates each capsule contains 40 mg of selpercatinib, includes storage instructions, and states the package contains 60 capsules. The labeler is Eli Lilly and Company.*

FDA Label Image

Retevmo 80mg 60ct 068 01

The label for Retevmo 80 mg capsules containing selpercatinib. The label indicates 60 capsules in the package, for oral use, prescription only. It includes storage instructions, manufacturer Eli Lilly and Company, and a website www.retevmo.com. The concentration of active ingredient per capsule is 80 mg.*

FDA Label Image

Chemical Structure (Retevmo Uspi Chem)

Chemical structure of selpercatinib, the active ingredient in RETEVMO. The diagram shows the molecular framework with nitrogen-containing heterocycles and functional groups relevant to its chemical composition.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.